Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.
Community Health Expo will be held from 9 a.m. to 12 noon on Saturday, April 5, in Western Park. The event is presented by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback